OTCBB:RGRX

Regenerx Biopharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy RGRX

*Your capital is at risk

$0.0006

+0 (+0%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

RGRX Prediction Chart

RGRX Predictions History

Latest community submissions for RGRX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
steven.r.rodriguez	Jan 17, 2023	Bullish	$0.150	X	—	0
NameNotImportant Pro	May 6, 2019	$0.179 -98.95%	$0.170	V	94.77%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RGRX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT REGENERX BIOPHARMACEUTICALS INC

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous sys...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by